Continuous Glucose Monitors Recommended in T1DM

This article originally appeared here.
Share this content:
Continuous Glucose Monitors Recommended in T1DM
Continuous Glucose Monitors Recommended in T1DM

FRIDAY, Sept. 30, 2016 (HealthDay News) -- Continuous glucose monitors are recommended for adults with type 1 diabetes, according to guidelines published online Sept. 2 in the Journal of Clinical Endocrinology and Metabolism.

Anne L. Peters, M.D., from the Keck School of Medicine in Los Angeles, and colleagues conducted a systematic literature review to develop evidence-based guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes.

The researchers found that continuous subcutaneous insulin infusion and continuous glucose monitoring have important roles in diabetes treatment. The existing studies support diabetes technology use for a variety of indications. The strongest recommendation was for individuals with type 1 diabetes who are able and willing to use the monitors. In addition, continuous glucose monitoring can be used on a short-term intermittent basis for individuals with type 2 diabetes. The use of insulin pumps was recommended over multiple insulin injections for individuals with type 1 diabetes who have not met their glycated hemoglobin goals. Pumps were also recommended for those with frequent hypoglycemia or glucose variability and for those with type 2 diabetes who are not meeting their glycemic goals.

"Scientific evidence supports the use of continuous glucose monitor technology in individuals with type 1 diabetes whose blood sugar is above the targeted level as well as those whose blood glucose is well managed," Peters said in a statement.

Several authors disclosed financial ties to the pharmaceutical and medical device industries.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »